BXCL701 is an oral small molecule DPP inhibitor that is being studied for use in several different cancers.
| SparkCures ID | 541 |
|---|---|
| Generic Name | BXCL701 |
| Additional Names | Talabostat |
| Treatment Classifications |
|
There are no resources, links or videos to display for this treatment.